Merck | MRK - Operating Expenses

Stock Price
111.90
Daily Change
-0.15 -0.13%
Monthly
5.42%
Yearly
-7.64%
Q2 Forecast
115.40

Merck reported EUR4.78B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Adidas EUR 5.91B 18M Dec/2025
Adyen EUR 766.45M 83.9M Jun/2025
Akzo Nobel EUR 2.13B 23M Mar/2026
Alcon AG USD 2.41B 123M Dec/2025
Amadeus IT EUR 1.28B 129M Dec/2025
Amarin USD 51.48M 113K Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 14.21B 372M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Beiersdorf EUR 4.16B 212M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Danone EUR 11.68B 239M Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Galapagos EUR 120.26M 7.43M Dec/2025
Genmab DKK 798M 235M Dec/2025
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Henkel EUR 8.67B 122M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Infineon EUR 3.27B 131M Dec/2025
Linde USD 6.52B 309M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
UCB EUR 2.96B 196M Dec/2025